Zeroing in on hepatic myofibroblasts while simultaneously addressing the underlying cause(s) of liver damage may be the key to reversing liver fibrosis. A new review by David Brenner, M.D., describes the emerging therapeutic approach.
An accomplished group of early-career researchers including postdoctoral scholars, graduate students and staff scientists showcased their work at Sanford Burnham Prebys’ 22nd Annual Trainee Research Symposium on Thursday, September 21st.
Svasti Haricharan, Ph.D., was the first guest on Stop & Talk—a new podcast offered by The Conrad Prebys Foundation. In the broadcast, Svasti shares how she came to be a research leader in therapy-resistant breast cancer and how race affects clinical outcomes.
Sanford Burnham Prebys Newsletter
Subscribe to our monthly email newsletter Discoveries.
Connect with us
Follow us on social media for the latest from Sanford Burnham Prebys.